Durable Protection after Anti-SARS-CoV-2 Monoclonal Antibody Therapy.
作者信息
Misch Elizabeth A
机构信息
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
出版信息
Kidney360. 2022 Jan 27;3(1):8-10. doi: 10.34067/KID.0007722021.
Abstract
摘要
相似文献
1
Durable Protection after Anti-SARS-CoV-2 Monoclonal Antibody Therapy.抗SARS-CoV-2单克隆抗体治疗后的持久保护作用。
Kidney360. 2022 Jan 27;3(1):8-10. doi: 10.34067/KID.0007722021.
2
Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.人类针对 SARS-CoV-2 刺突蛋白受体结合域的中和抗体的结构基础。
Microbiol Spectr. 2021 Oct 31;9(2):e0135221. doi: 10.1128/Spectrum.01352-21. Epub 2021 Oct 13.
3
Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19.奥密克戎时代 COVID-19 中和单克隆抗体治疗的现状与发展策略。
Viruses. 2023 May 31;15(6):1297. doi: 10.3390/v15061297.
4
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).单克隆抗体治疗作为潜在治疗干预手段用于新型冠状病毒病-19（COVID-19）的观点。
Asian Pac J Allergy Immunol. 2020 Mar;38(1):10-18. doi: 10.12932/AP-200220-0773.
5
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies.严重急性呼吸综合征冠状病毒2型奥密克戎亚变体对治疗性单克隆抗体的中和敏感性
Lancet Infect Dis. 2022 Jul;22(7):942-943. doi: 10.1016/S1473-3099(22)00365-6. Epub 2022 Jun 9.
6
A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants.一种四价双特异性抗体优于其亲本抗体的组合，能中和多种 SARS-CoV-2 变体。
Clin Immunol. 2024 Mar;260:109902. doi: 10.1016/j.clim.2024.109902. Epub 2024 Jan 11.
7
COVID-19 Antibody Trials Have Begun.新冠病毒抗体试验已经开始。
JAMA. 2020 Jul 14;324(2):128. doi: 10.1001/jama.2020.11582.
8
Neutralizing monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的中和单克隆抗体。
Nat Rev Immunol. 2021 Jun;21(6):382-393. doi: 10.1038/s41577-021-00542-x. Epub 2021 Apr 19.
9
Inhalable neutralizing antibodies - promising approach to combating respiratory viral infections.可吸入中和抗体——抗击呼吸道病毒感染的有前途的方法。
Trends Pharmacol Sci. 2023 Feb;44(2):85-97. doi: 10.1016/j.tips.2022.11.006. Epub 2022 Dec 22.
10
COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase.新型冠状病毒肺炎与严重急性呼吸综合征冠状病毒2：用于即刻救援和恢复阶段的抗体
Front Immunol. 2020 May 29;11:1196. doi: 10.3389/fimmu.2020.01196. eCollection 2020.
本文引用的文献
1
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.SARS-CoV-2 中和单克隆抗体治疗肾移植受者的 COVID-19。
Kidney360. 2021 Oct 20;3(1):133-143. doi: 10.34067/KID.0005732021. eCollection 2022 Jan 27.
2
Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.COVID-19 单克隆抗体治疗在实体器官移植受者中的应用。
Transpl Infect Dis. 2022 Feb;24(1):e13759. doi: 10.1111/tid.13759. Epub 2021 Dec 7.
3
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.mRNA 疫苗接种与 COVID-19 住院和疾病严重程度的关联。
JAMA. 2021 Nov 23;326(20):2043-2054. doi: 10.1001/jama.2021.19499.
4
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.Sotrovimab 对 SARS-CoV-2 中和抗体用于治疗新型冠状病毒早期感染。
N Engl J Med. 2021 Nov 18;385(21):1941-1950. doi: 10.1056/NEJMoa2107934. Epub 2021 Oct 27.
5
Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients.实体器官移植受者中COVID-19的单克隆抗体治疗
Open Forum Infect Dis. 2021 Jun 7;8(6):ofab255. doi: 10.1093/ofid/ofab255. eCollection 2021 Jun.
6
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.REGEN-COV 抗体组合在门诊 COVID-19 患者中的应用及结果。
N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29.
7
Racial and Ethnic Disparities in SARS-CoV-2 Testing and COVID-19 Outcomes in a Medicaid Managed Care Cohort.医疗补助管理式照护队列中SARS-CoV-2检测及新冠病毒病结局的种族和族裔差异
Am J Prev Med. 2021 Nov;61(5):644-651. doi: 10.1016/j.amepre.2021.05.015. Epub 2021 Jul 16.
8
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.移植受者中第三剂mRNA-1273疫苗的随机试验。
N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.
9
Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.COVID-19 疫苗在实体器官移植受者中的临床效果。
Transpl Infect Dis. 2021 Oct;23(5):e13705. doi: 10.1111/tid.13705. Epub 2021 Aug 3.
10
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.巴尼韦单抗/依特司韦单抗在轻中度 COVID-19 中的应用。
N Engl J Med. 2021 Oct 7;385(15):1382-1392. doi: 10.1056/NEJMoa2102685. Epub 2021 Jul 14.
Zotero 插件